Medicare Alliance for Beneficiary Access (Maba)

Alliance of Providers Working on Protecting Patient Access

Based in VA

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $40K in lobbying spend across 2 quarterly filings, Medicare Alliance for Beneficiary Access (Maba) is an active lobbying client. Their lobbying covers 1 issue area.

$40K
Total Spend
1
Years Active
1
Firms Hired
1
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2025$40K

Issues Lobbied

Medicare/Medicaid

Lobbying Firms

The Mcmanus Group

Lobbyists

John Mcmanus

Government Agencies Targeted

These are the government entities that Medicare Alliance for Beneficiary Access (Maba) disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATE
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid

Access to Physicians

Improve beneficiary access with altered cost sharing

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?

Related Investigations

Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

National Community Pharmacists Association
$15.4M total spend
Healthcare Distribution Alliance (Formerly - Hdma)
$13.2M total spend
American Academy of Otolaryngology-head and Neck Surgery
$8.0M total spend
Infectious Diseases Society of America
$5.1M total spend
National Hospice and Palliative Care Organization
$5.0M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.